NASDAQ:BTTX

Better Therapeutics Stock Insider Trading

etoro logo Buy BTTX
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Jun 03, 2026

Better Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 23.43M and sold 0 BTTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 23.43M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 07, 2023
Buy
Stock Option (Right to Buy)
A-Award
Perry David P
Executive Chairman
CEO / President 15 000
Value: $11.6K
Jun 07, 2023
Buy
Stock Option (Right to Buy)
A-Award
Parker Geoffrey M.
Director
Director 15 000
Value: $11.6K
Jun 07, 2023
Buy
Stock Option (Right to Buy)
A-Award
Lavizzo-mourey Risa J
Director
Director 15 000
Value: $11.6K
Jun 07, 2023
Buy
Stock Option (Right to Buy)
A-Award
Armanino Andrew J.
Director
Director 15 000
Value: $11.6K
Jun 07, 2023
Buy
Stock Option (Right to Buy)
A-Award
Granger Elder
Director
Director 15 000
Value: $11.6K
Jun 07, 2023
Buy
Stock Option (Right to Buy)
A-Award
Carmona Richard H
Director
Director 15 000
Value: $11.6K
May 16, 2023
Buy
Common Stock
P-Purchase
Granger Elder
Director
Director 600
Value: $520
May 16, 2023
Buy
Common Stock
P-Purchase
Granger Elder
Director
Director 600
Value: $520
Apr 10, 2023
Buy
Common Stock
Georgianna Maule-ffinch 2015 Trust
10 Percent Owner
10% Owner 0
Value: $0
Apr 10, 2023
Buy
Common Stock
Georgianna Maule-ffinch 2015 Trust
10 Percent Owner
10% Owner 0
Value: $0
Apr 10, 2023
Buy
Common Stock
P-Purchase
Armanino Andrew J.
Director
Director 303 030
Value: $250.0K
Apr 10, 2023
Buy
Common Stock
P-Purchase
Armanino Andrew J.
Director
Director 303 030
Value: $250.0K
Apr 10, 2023
Buy
Common Stock
P-Purchase
Parker Geoffrey M.
Director
Director 303 030
Value: $250.0K
Apr 10, 2023
Buy
Common Stock
P-Purchase
Karbe Frank
See Remarks
Officer 242 424
Value: $200.0K
Apr 10, 2023
Buy
Common Stock
P-Purchase
Perry David P
See Remarks
Officer 3 636 364
Value: $3.00M
Apr 10, 2023
Buy
Common Stock
P-Purchase
Perry David P
See Remarks
Officer 1 333 333
Value: $1.10M
Apr 10, 2023
Buy
Common Stock
P-Purchase
Parker Geoffrey M.
Director
Director 303 030
Value: $250.0K
Apr 10, 2023
Buy
Common Stock
P-Purchase
Perry David P
See Remarks
Officer 1 333 333
Value: $1.10M
Apr 10, 2023
Buy
Common Stock
P-Purchase
Perry David P
See Remarks
Officer 3 636 364
Value: $3.00M
Apr 10, 2023
Buy
Common Stock
P-Purchase
Karbe Frank
See Remarks
Officer 242 424
Value: $200.0K
Apr 05, 2023
Buy
Common Stock
A-Award
Berman Mark A.
Chief Medical Officer
Officer 101 450
Value: $0
Apr 05, 2023
Buy
Common Stock
A-Award
Heinen Mark
Chief Financial Officer
C-Suite Officer 54 000
Value: $0
Apr 05, 2023
Buy
Common Stock
A-Award
Wynholds Kristin
Chief Product Officer
Officer 101 450
Value: $0
Apr 05, 2023
Buy
Common Stock
A-Award
Heinen Mark
Chief Financial Officer
C-Suite Officer 54 000
Value: $0
Apr 05, 2023
Buy
Common Stock
A-Award
Wynholds Kristin
Chief Product Officer
Officer 101 450
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BETTER THERAPEUTICS, INC.
Better Therapeutics
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also in...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE